Minor
Cabozantinib With · Refractory GCTs
Trial completed
Also in this update: Primary completion date changed from estimate of Jan 2027 to Jul 31, 2026
Jennifer KingPhase 2 NCT04876456 Registry history of NCT04876456 on ClinicalTrials.gov (opens the registry)